Contact patients currently taking Esmya for uterine fibroids as soon as possible and advise them to stop their treatment.
Caution should be used in patients with known risk factors for venous thromboembolism in addition to the underlying disease.
Discontinue baricitinib treatment permanently if clinical features of deep vein thrombosis or pulmonary embolism occur.
SGLT2 inhibitor treatment should be interrupted in patients who are hospitalised for major surgical procedures or acute serious medical illnesses and ketone levels measured, preferably in blood rather than urine.
Benzodiazepines and opioids can both cause respiratory depression, which can be fatal if not recognised in time.
Letters were sent on Typhim Vi vaccines, Mepact (mifamurtide), and Xeljanz (tofacitinib) and an alert issued to recall Emerade 150 microgram adrenaline pens.
Alerts were issued about CME T34 and T34L (T60) ambulatory syringe pumps, Cardinal Health tympanic thermometers, t:slim X2 insulin pump, and Mavidon skin preparation electrode gels.